Skip to content

Industrial Pharmacist

  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy
  • ANDA
  • ADL
  • FRD
  • QbD
  • QA
  • QC
  • RA
  • FDA
  • VS
  • SCM
  • Q&A
  • Dissolution
  • Data Integrity
  • Validation
  • Manufacturing
  • Packaging
  • Microbiology
Industrial Pharmacist
  • Innovator, Generic Drug and Reference Standard | A Comprehensive Review
    VS

    Innovator, Generic Drug and Reference Standard | A Comprehensive Review

    Byipharmacist January 3, 2024September 9, 2024

    Innovator An innovator in the context of drugs refers to the original developer or manufacturer of a new pharmaceutical product.  – Example: Astellas is the innovator of Veozah, as they researched, developed, and brought the drug to market first.   Generic Drug Generic drugs are generic versions of a pharmaceutical product that are approved as…

    Read More Innovator, Generic Drug and Reference Standard | A Comprehensive ReviewContinue

  • Common Tablet Manufacturing Defects in Pharma | Part-3
    Manufacturing | Tablet

    Common Tablet Manufacturing Defects in Pharma | Part-3

    Byipharmacist December 29, 2023September 9, 2024

    Black Spots Black-colored specks or dots on the tablet surface. Causes of Black Spots:   Remedies for Black Spots:   Inconsistent Thickness Variations in the tablet thickness within a batch or across different tablets. Causes of Inconsistent Thickness:   Remedies for Inconsistent Thickness:   Hardness Variation Inconsistency in tablet hardness across a batch or within…

    Read More Common Tablet Manufacturing Defects in Pharma | Part-3Continue

  • Common Tablet Manufacturing Defects in Pharma | Part-2
    Manufacturing | Tablet

    Common Tablet Manufacturing Defects in Pharma | Part-2

    Byipharmacist December 29, 2023September 9, 2024

    Mottling Uneven distribution of color or pigmentation on the tablet surface. Causes of Mottling:          Remedies for Mottling:   Flashing It presents as a thin, unwanted edge around the perimeter of a tablet. Causes of Flashing:   Remedies for Flashing:   Chipping Breakage of tablet edges, resulting in small chips or fragments….

    Read More Common Tablet Manufacturing Defects in Pharma | Part-2Continue

  • Common Tbalet Manufacturing Defects in Pharma | Part-1
    Manufacturing | Tablet

    Common Tbalet Manufacturing Defects in Pharma | Part-1

    Byipharmacist December 29, 2023September 9, 2024

    1. Capping Partial or complete separation of a tablet’s crown or upper portion from the main body. Causes of Capping: Remedies for Capping:   2. Lamination Tablets split into layers or laminates. Causes of Lamination:   Remedies for Lamination:   3. Sticking It happens when the tablet material adheres to the punches and dies instead…

    Read More Common Tbalet Manufacturing Defects in Pharma | Part-1Continue

  • Difference Between Aseptic Process and Terminal Sterilization
    VS

    Difference Between Aseptic Process and Terminal Sterilization

    Byipharmacist December 21, 2023September 9, 2024

    Similarities 1. Both aseptic and terminal sterile manufacturing processes aim to prevent contamination of pharmaceutical products. 2. Both processes require strict adherence to Good Manufacturing Practices (GMP) guidelines. 3. Both processes involve the use of specialized equipment and facilities to maintain a controlled environment.   Differences 1. Aseptic manufacturing involves the use of aseptic techniques,…

    Read More Difference Between Aseptic Process and Terminal SterilizationContinue

  • Process Capability and Continual Improvement in QbD
    QbD

    Process Capability and Continual Improvement in QbD

    Byipharmacist December 19, 2023September 9, 2024

    Process capability measures the inherent variability of a stable process that is in a state of statistical control in relation to the established acceptance criteria.    Calculations based on the inherent variability due to common cause of a stable process (i.e., in a state of statistical control) result in process capability (Cp and Cpk) indices….

    Read More Process Capability and Continual Improvement in QbDContinue

  • Difference Between CSV and CSA
    CSV | VS

    Difference Between CSV and CSA

    Byipharmacist December 18, 2023September 9, 2024

    Introduction In September 2022, the U.S. Food and Drug Administration (FDA) released a draft guidance on software validation, introducing a new approach called Computer Software Assurance (CSA) for production and quality system software. This guidance marks a shift from the traditional method of software validation, known as computer system validation (CSV), towards a risk-based approach….

    Read More Difference Between CSV and CSAContinue

  • Control Strategy in QbD
    QbD

    Control Strategy in QbD

    Byipharmacist December 14, 2023September 9, 2024

    The knowledge gained through appropriately designed development studies culminates in the establishment of a control strategy. As shown in the picture, control strategy could include three levels of controls as follows:   Level 1 utilizes automatic engineering control to monitor the CQAs of the output materials in real time. This level of control is the…

    Read More Control Strategy in QbDContinue

Page navigation

Previous PagePrevious 1 … 27 28 29 30 31 … 43 Next PageNext

Popular Articles

  • Calculation of Peak Purity in HPLC

    Calculation of Peak Purity in HPLC

  • Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

    Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

  • Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

    Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

  • Audits in the Pharmaceutical Industry | Internal vs External

    Audits in the Pharmaceutical Industry | Internal vs External

  • USFDA Complaint Laboratory KPIs Measurements

    USFDA Complaint Laboratory KPIs Measurements

  • Difference Between Generic ANDA and 505(b)(2) Submissions

    Difference Between Generic ANDA and 505(b)(2) Submissions

  • Difference Between Disinfection and Sterilization

    Difference Between Disinfection and Sterilization

  • Key Elements of an Analytical Worksheet

    Key Elements of an Analytical Worksheet

  • Interview Questions and Answers on GMP

    Interview Questions and Answers on GMP

  • Quality by Design (QbD) and Design Space in Pharmaceutical Development

    Quality by Design (QbD) and Design Space in Pharmaceutical Development

  • CPP and CQA in Different Stages of Drug Product Manufacturing

    CPP and CQA in Different Stages of Drug Product Manufacturing

  • FDA Recall Classification System

    FDA Recall Classification System

  • Analytical Test Method Validation and Verification

    Analytical Test Method Validation and Verification

  • GLP vs GMP vs GCP | Similarities and Differences

    GLP vs GMP vs GCP | Similarities and Differences

  • Pharmaceutical Validation Interview Questions and Answers

    Pharmaceutical Validation Interview Questions and Answers

  • Difference Between Purity and Potency

    Difference Between Purity and Potency

  • Difference Between RLD and RS

    Difference Between RLD and RS

  • USFDA Databases

    USFDA Databases

  • Regulatory Requirements for Reprocess and Re-work

    Regulatory Requirements for Reprocess and Re-work

  • What Does FDA Regulate?

    What Does FDA Regulate?

© 2025 Industrial Pharmacist

  • Privacy Policy
  • DMCA
  • Contact Us
Industrial Pharmacist
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy